Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.
Bernasconi E, Boubaker K, Junghans C, Flepp M, Furrer HJ, Haensel A, Hirschel B, Boggian K, Chave JP, Opravil M, Weber R, Rickenbach M, Telenti A; Swiss HIV Cohort Study. Bernasconi E, et al. Among authors: telenti a. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):50-5. doi: 10.1097/00126334-200209010-00007. J Acquir Immune Defic Syndr. 2002. PMID: 12352150
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Rotger M, Bayard C, Taffé P, Martinez R, Cavassini M, Bernasconi E, Battegay M, Hirschel B, Furrer H, Witteck A, Weber R, Ledergerber B, Telenti A, Tarr PE; Swiss HIV Cohort Study. Rotger M, et al. Among authors: telenti a. Circ Cardiovasc Genet. 2009 Dec;2(6):621-8. doi: 10.1161/CIRCGENETICS.109.874412. Epub 2009 Sep 18. Circ Cardiovasc Genet. 2009. PMID: 20031643
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, Decosterd LA, Furrer H, Opravil M, Pantaleo G, Retelska D, Ruiz L, Schinkel AH, Vernazza P, Eap CB, Telenti A; Swiss HIV Cohort Study. Fellay J, et al. Among authors: telenti a. Lancet. 2002 Jan 5;359(9300):30-6. doi: 10.1016/S0140-6736(02)07276-8. Lancet. 2002. PMID: 11809184
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.
Greub G, Cozzi-Lepri A, Ledergerber B, Staszewski S, Perrin L, Miller V, Francioli P, Furrer H, Battegay M, Vernazza P, Bernasconi E, Günthard HF, Hirschel B, Phillips AN, Telenti A; Frankfurt HIV Clinic Cohort and the Swiss HIV Cohort Study. Greub G, et al. Among authors: telenti a. AIDS. 2002 Sep 27;16(14):1967-9. doi: 10.1097/00002030-200209270-00017. AIDS. 2002. PMID: 12351960 No abstract available.
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.
Jaggy C, von Overbeck J, Ledergerber B, Schwarz C, Egger M, Rickenbach M, Furrer HJ, Telenti A, Battegay M, Flepp M, Vernazza P, Bernasconi E, Hirschel B; Swiss HIV Cohort Study. Jaggy C, et al. Among authors: telenti a. Lancet. 2003 Sep 13;362(9387):877-8. doi: 10.1016/S0140-6736(03)14307-3. Lancet. 2003. PMID: 13678976
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M; Swiss HIV Cohort Study Group. Kaufmann GR, et al. Among authors: telenti a. Arch Intern Med. 2003 Oct 13;163(18):2187-95. doi: 10.1001/archinte.163.18.2187. Arch Intern Med. 2003. PMID: 14557216
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
Young J, De Geest S, Spirig R, Flepp M, Rickenbach M, Furrer H, Bernasconi E, Hirschel B, Telenti A, Vernazza P, Battegay M, Bucher HC; Swiss HIV Cohort Study Group. Young J, et al. Among authors: telenti a. BMJ. 2004 Jan 3;328(7430):15. doi: 10.1136/bmj.328.7430.15. BMJ. 2004. PMID: 14703538 Free PMC article.
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
Tarr PE, Taffé P, Bleiber G, Furrer H, Rotger M, Martinez R, Hirschel B, Battegay M, Weber R, Vernazza P, Bernasconi E, Darioli R, Rickenbach M, Ledergerber B, Telenti A; Swiss HIV Cohort Study. Tarr PE, et al. Among authors: telenti a. J Infect Dis. 2005 May 1;191(9):1419-26. doi: 10.1086/429295. Epub 2005 Mar 22. J Infect Dis. 2005. PMID: 15809899 Free article.
598 results